BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

74 related articles for article (PubMed ID: 7287679)

  • 21. Heparin from bovine intestinal mucosa: glycans with multiple sulfation patterns and anticoagulant effects.
    Tovar AM; Capillé NV; Santos GR; Vairo BC; Oliveira SN; Fonseca RJ; Mourão PA
    Thromb Haemost; 2012 May; 107(5):903-15. PubMed ID: 22437650
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Biological implications of the structural, antithrombin affinity and anticoagulant activity relationships among vertebrate heparins and heparan sulphates.
    Hovingh P; Piepkorn M; Linker A
    Biochem J; 1986 Jul; 237(2):573-81. PubMed ID: 2948492
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Location of antithrombin-binding regions in rat skin heparin proteoglycans.
    Jacobsson KG; Lindahl U; Horner AA
    Biochem J; 1986 Dec; 240(3):625-32. PubMed ID: 3827857
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Mechanism of inhibition of mammalian DNA topoisomerase I by heparin.
    Ishii K; Futaki S; Uchiyama H; Nagasawa K; Andoh T
    Biochem J; 1987 Jan; 241(1):111-9. PubMed ID: 3032152
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Binding to antithrombin of heparin fractions with different molecular weights.
    Danielsson A; Björk I
    Biochem J; 1981 Feb; 193(2):427-33. PubMed ID: 7305940
    [TBL] [Abstract][Full Text] [Related]  

  • 26. High and low affinity heparin compared with unfractionated heparin as antithrombotic drugs.
    Merton RE; Thomas DP; Havercroft SJ; Barrowcliffe TW; Lindahl U
    Thromb Haemost; 1984 Apr; 51(2):254-6. PubMed ID: 6740557
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Commercial antithrombin concentrate contains inactive L-forms of antithrombin.
    Chang WS; Harper PL
    Thromb Haemost; 1997 Feb; 77(2):323-8. PubMed ID: 9157590
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Structure-activity relationships of heparin. Independence of heparin charge density and antithrombin-binding domains in thrombin inhibition by antithrombin and heparin cofactor II.
    Hurst RE; Poon MC; Griffith MJ
    J Clin Invest; 1983 Sep; 72(3):1042-5. PubMed ID: 6688430
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Separation of heparin into subfractions by DEAE-cellulose chromatography.
    Yue RH; Starr T; Gertler MM
    Thromb Haemost; 1980 Feb; 42(5):1452-9. PubMed ID: 7368152
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Anticoagulant effect of unfractionated heparin in antithrombin-depleted plasma in vitro.
    Krulder JW; Strebus AF; Meinders AE; Briët E
    Haemostasis; 1996; 26(2):85-9. PubMed ID: 9119287
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Polysaccharides from the skin of the ray Raja radula. Partial characterization and anticoagulant activity.
    Ben Mansour M; Majdoub H; Bataille I; Roudesli MS; Hassine M; Ajzenberg N; Chaubet F; Maaroufi RM
    Thromb Res; 2009 Feb; 123(4):671-8. PubMed ID: 18617224
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Purification and properties of guinea pig antithrombin III.
    Heck L; Rosenberg R; Remold H
    Prep Biochem; 1979; 9(4):359-77. PubMed ID: 504072
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Fractionation of heparin using antithrombin III reversibly bound to concanavalin A-sepharose.
    Denton J; Lewis WE; Nieduszynski IA; Phelps CF
    Anal Biochem; 1981 Dec; 118(2):388-91. PubMed ID: 7337233
    [No Abstract]   [Full Text] [Related]  

  • 34. Anticoagulantly active heparin from clam (Mercenaria mercenaria).
    Jordan RE; Marcum JA
    Arch Biochem Biophys; 1986 Aug; 248(2):690-5. PubMed ID: 3740845
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Anticoagulant properties of heparin and heparin fractions.
    Holmer E
    Scand J Haematol Suppl; 1980; 36():25-39. PubMed ID: 6935760
    [No Abstract]   [Full Text] [Related]  

  • 36. Purification and further characterization of antithrombin III Milano: lack of reactivity with thrombin.
    Wolf M; Boyer-Neumann C; Meyer D; Tripodi A; Mannucci PM; Larrieu MJ
    Thromb Haemost; 1987 Oct; 58(3):888-92. PubMed ID: 3433251
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The oligosaccharide side chain on Asn-135 of alpha-antithrombin, absent in beta-antithrombin, decreases the heparin affinity of the inhibitor by affecting the heparin-induced conformational change.
    Turk B; Brieditis I; Bock SC; Olson ST; Björk I
    Biochemistry; 1997 Jun; 36(22):6682-91. PubMed ID: 9184148
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Generation of affinity for antithrombin III by supplemental sulfation of heparin species with low affinity for the protein.
    Ogamo A; Metori A; Uchiyama H; Nagasawa K
    J Biochem; 1990 Oct; 108(4):588-92. PubMed ID: 2292586
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Structures of the oligosaccharide chains of two forms of alpha 1-acid glycoprotein purified from liver metastases of lung, colon, and breast tumors.
    Chandrasekaran EV; Davila M; Nixon D; Mendicino J
    Cancer Res; 1984 Apr; 44(4):1557-67. PubMed ID: 6704968
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The structure of heparin oligosaccharide fragments with high anti-(factor Xa) activity containing the minimal antithrombin III-binding sequence. Chemical and 13C nuclear-magnetic-resonance studies.
    Casu B; Oreste P; Torri G; Zoppetti G; Choay J; Lormeau JC; Petitou M; Sinäy P
    Biochem J; 1981 Sep; 197(3):599-609. PubMed ID: 7325974
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.